Target genes discovery through copy number alteration analysis in human hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 19, Issue 47, 2013, Pages 8873-8879

  Gu, De Leung ^a,c   Chen, Yen Hsieh ^a,b   Shih, Jou Ho ^a,d   Lin, Chi Hung ^c   Jou, Yuh Shan ^a   Chen, Chian Feng ^c  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b ACADEMIA SINICA   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Copy number alteration; Driver genes; Hepato cellular carcinoma; High density single nucleotide polymorphism arrays

Indexed keywords

ARGONAUTE 2 PROTEIN; AXIN; BETA CATENIN; BRCA2 PROTEIN; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 2; JANUS KINASE; KELCH LIKE ECH ASSOCIATED PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MICRORNA; MIXED LINEAGE LEUKEMIA PROTEIN; P21 ACTIVATED KINASE 1; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN P16; PROTEIN P53; RETINOBLASTOMA PROTEIN; SMAD2 PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN;

ARID1A GENE; ARID2 GENE; ARTICLE; CELL MIGRATION; COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER VARIATION; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; FNDC3B GENE; GENE; GENE EXPRESSION; GENE MUTATION; GENOMIC IN SITU HYBRIDIZATION; HIGH THROUGHPUT SEQUENCING; HUMAN; IER3 GENE; KARYOTYPING; LIVER CELL CARCINOMA; MLL GENE; MLL2 GENE; MLL3 GENE; MLL4 GENE; ONCOGENE C MYC; PAK1 GENE; RISK FACTOR; RPS6KA3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

COPY NUMBER ALTERATION; DRIVER GENES; HEPATOCELLULAR CARCINOMA; HIGH-DENSITY SINGLE NUCLEOTIDE POLYMORPHISM ARRAYS;

ANIMALS; CARCINOMA, HEPATOCELLULAR; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DNA COPY NUMBER VARIATIONS; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; LIVER NEOPLASMS; MUTATION; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 84890954154     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i47.8873     Document Type: Article

References (60)

1. Bruix J, Boix L, Sala M, Llovet JM. Focus on hepatocellular carcinoma. Cancer Cell 2004; 5: 215-219 [PMID: 15050913 DOI: 10.1016/S1535-6108(04)00058-3]
2. Bosch FX, Ribes J, Díaz M, Cléries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127: S5-S16 [PMID: 15508102 DOI: 10.1053/j.gastro.2004.09.011]
3. Benowitz S. Liver cancer biomarkers struggling to succeed. J Natl Cancer Inst 2007; 99: 590-591 [PMID: 17440159 DOI: 10.1093/jnci/djk174]
4. Goldman JM, Melo JV. Chronic myeloid leukemia--advanc-es in biology and new approaches to treatment. N Engl J Med 2003; 349: 1451-1464 [PMID: 14534339 DOI: 10.1056/ NEJMra020777]
5. Pao W, Miller V, Zakowski M, Doherty J, Politi K, Sarkaria I, Singh B, Heelan R, Rusch V, Fulton L, Mardis E, Kupfer D, Wilson R, Kris M, Varmus H. EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to geftinib and erlo-tinib. Proc Natl Acad Sci USA 2004; 101: 13306-13311 [PMID: 15329413 DOI: 10.1073/pnas.0405220101]
6. Hudis CA. Trastuzumab--mechanism of action and use in clinical practice. N Engl J Med 2007; 357: 39-51 [PMID: 17611206 DOI: 10.1056/NEJMra043186]
7. Frenette C, Gish R. Targeted systemic therapies for hepa-tocellular carcinoma: clinical perspectives, challenges and implications. World J Gastroenterol 2012; 18: 498-506 [PMID: 22363115 DOI: 10.3748/wjg.v18.i6.498]
8. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390 [PMID: 18650514 DOI: 10.1056/NEJMoa0708857]
9. Cheng AL, Kang YK, Chen Z, Tsao CJ, Qin S, Kim JS, Luo R, Feng J, Ye S, Yang TS, Xu J, Sun Y, Liang H, Liu J, Wang J, Tak WY, Pan H, Burock K, Zou J, Voliotis D, Guan Z. Efficacy and safety of sorafenib in patients in the Asia-Pacifc region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol 2009; 10: 25-34 [PMID: 19095497 DOI: 10.1016/ S1470-2045(08)70285-7]
10. Wang G, Zhao Y, Liu X, Wang L, Wu C, Zhang W, Liu W, Zhang P, Cong W, Zhu Y, Zhang L, Chen S, Wan D, Zhao X, Huang W, Gu J. Allelic loss and gain, but not genomic instability, as the major somatic mutation in primary hepatocel-lular carcinoma. Genes Chromosomes Cancer 2001; 31: 221-227 [PMID: 11391792 DOI: 10.1002/gcc.1138]
11. Knuutila S, Aalto Y, Autio K, Björkqvist AM, El-Rifai W, Hemmer S, Huhta T, Kettunen E, Kiuru-Kuhlefelt S, Larramendy ML, Lushnikova T, Monni O, Pere H, Tapper J, Tarkkanen M, Varis A, Wasenius VM, Wolf M, Zhu Y. DNA copy number losses in human neoplasms. Am J Pathol 1999; 155: 683-694 [PMID: 10487825 DOI: 10.1016/ S0002-9440(10)65166-8]
12. Kusano N, Shiraishi K, Kubo K, Oga A, Okita K, Sasaki K. Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: their relationship to clinicopathological features. Hepatology 1999; 29: 1858-1862 [PMID: 10347130 DOI: 10.1002/hep.510290636]
13. Niketeghad F, Decker HJ, Caselmann WH, Lund P, Geissler F, Dienes HP, Schirmacher P. Frequent genomic imbalances suggest commonly altered tumour genes in human hepatocarcinogenesis. Br J Cancer 2001; 85: 697-704 [PMID: 11531255 DOI: 10.1054/bjoc.2001.1963]
14. Matsuda Y, Ichida T, Matsuzawa J, Sugimura K, Asakura H. p16(INK4) is inactivated by extensive CpG methyla-tion in human hepatocellular carcinoma. Gastroenterology 1999; 116: 394-400 [PMID: 9922321 DOI: 10.1016/S0016-5085(99)70137-X]
15. Murata H, Tsuji S, Tsujii M, Sakaguchi Y, Fu HY, Kawano S, Hori M. Promoter hypermethylation silences cyclooxy-genase-2 (Cox-2) and regulates growth of human hepatocel-lular carcinoma cells. Lab Invest 2004; 84: 1050-1059 [PMID: 15156159 DOI: 10.1038/labinvest.3700118]
16. Breuhahn K, Gores G, Schirmacher P. Strategies for hepato-cellular carcinoma therapy and diagnostics: lessons learned from high throughput and profiling approaches. Hepatol-ogy 2011; 53: 2112-2121 [PMID: 21433041 DOI: 10.1002/ hep.24313]
17. Giordano S, Columbano A. MicroRNAs: new tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma? Hepatology 2013; 57: 840-847 [PMID: 23081718 DOI: 10.1002/ hep.26095]
18. Khare S, Zhang Q, Ibdah JA. Epigenetics of hepatocellular carcinoma: role of microRNA. World J Gastroenterol 2013; 19: 5439-5445 [PMID: 24023486 DOI: 10.3748/wjg.v19.i33.5439]
19. Ozturk M. p53 mutation in hepatocellular carcinoma after afatoxin exposure. Lancet 1991; 338: 1356-1359 [PMID: 1682737 DOI: 10.1016/0140-6736(91)92236-U]
20. de La Coste A, Romagnolo B, Billuart P, Renard CA, Buen-dia MA, Soubrane O, Fabre M, Chelly J, Beldjord C, Kahn A, Perret C. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 1998; 95: 8847-8851 [PMID: 9671767 DOI: 10.1073/pnas.95.15.8847]
21. De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/IGF2R gene is mutated in human hepatocel-lular carcinomas with loss of heterozygosity. Nat Genet 1995; 11: 447-449 [PMID: 7493029 DOI: 10.1038/ng1295-447]
22. Katagiri T, Nakamura Y, Miki Y. Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res 1996; 56: 4575-4577 [PMID: 8840963]
23. Yakicier MC, Irmak MB, Romano A, Kew M, Ozturk M. Smad2 and Smad4 gene mutations in hepatocellular carcinoma. Oncogene 1999; 18: 4879-4883 [PMID: 10490821 DOI: 10.1038/sj.onc.1202866]
24. Zhao X, Li J, He Y, Lan F, Fu L, Guo J, Zhao R, Ye Y, He M, Chong W, Chen J, Zhang L, Yang N, Xu B, Wu M, Wan D, Gu J. A novel growth suppressor gene on chromosome 17p13.3 with a high frequency of mutation in human hepa-tocellular carcinoma. Cancer Res 2001; 61: 7383-7387 [PMID: 11606366]
25. Yao YJ, Ping XL, Zhang H, Chen FF, Lee PK, Ahsan H, Chen CJ, Lee PH, Peacocke M, Santella RM, Tsou HC. PTEN/ MMAC1 mutations in hepatocellular carcinomas. Onco-gene 1999; 18: 3181-3185 [PMID: 10340391 DOI: 10.1038/ sj.onc.1202659]
26. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nat Genet 2000; 24: 245-250 [PMID: 10700176 DOI: 10.1038/73448]
27. Li M, Zhao H, Zhang X, Wood LD, Anders RA, Choti MA, Pawlik TM, Daniel HD, Kannangai R, Offerhaus GJ, Vel-culescu VE, Wang L, Zhou S, Vogelstein B, Hruban RH, Pa-padopoulos N, Cai J, Torbenson MS, Kinzler KW. Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 2011; 43: 828-829 [PMID: 21822264 DOI: 10.1038/ng.903]
28. Guichard C, Amaddeo G, Imbeaud S, Ladeiro Y, Pelletier L, Maad IB, Calderaro J, Bioulac-Sage P, Letexier M, Degos F, Clément B, Balabaud C, Chevet E, Laurent A, Couchy G, Letouzé E, Calvo F, Zucman-Rossi J. Integrated analysis of somatic mutations and focal copy-number changes identi-fes key genes and pathways in hepatocellular carcinoma. Nat Genet 2012; 44: 694-698 [PMID: 22561517 DOI: 10.1038/ ng.2256]
29. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH, Aoki M, Hosono N, Kubo M, Miya F, Arai Y, Takahashi H, Shirakihara T, Nagasaki M, Shibuya T, Na-kano K, Watanabe-Makino K, Tanaka H, Nakamura H, Ku-suda J, Ojima H, Shimada K, Okusaka T, Ueno M, Shigeka-wa Y, Kawakami Y, Arihiro K, Ohdan H, Gotoh K, Ishikawa O, Ariizumi S, Yamamoto M, Yamada T, Chayama K, Kosuge T, Yamaue H, Kamatani N, Miyano S, Nakagama H, Nakamura Y, Tsunoda T, Shibata T, Nakagawa H. Whole- genome sequencing of liver cancers identifies etiological infuences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44: 760-764 [PMID: 22634756 DOI: 10.1038/ng.2291]
30. Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, Zhu ZD, Zhou B, Liu XY, Liu RF, Fei QL, Chen H, Cai B, Zhou B, Xiao HS, Qin LX, Han ZG. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet 2012; 44: 1117-1121 [PMID: 22922871 DOI: 10.1038/ng.2391]
31. Cleary SP, Jeck WR, Zhao X, Chen K, Selitsky SR, Savich GL, Tan TX, Wu MC, Getz G, Lawrence MS, Parker JS, Li J, Powers S, Kim H, Fischer S, Guindi M, Ghanekar A, Chiang DY. Identification of driver genes in hepatocellular carcinoma by exome sequencing. Hepatology 2013 May 31; Epub ahead of print [PMID: 23728943 DOI: 10.1002/hep.26540]
32. Kan Z, Zheng H, Liu X, Li S, Barber TD, Gong Z, Gao H, Hao K, Willard MD, Xu J, Hauptschein R, Rejto PA, Fernandez J, Wang G, Zhang Q, Wang B, Chen R, Wang J, Lee NP, Zhou W, Lin Z, Peng Z, Yi K, Chen S, Li L, Fan X, Yang J, Ye R, Ju J, Wang K, Estrella H, Deng S, Wei P, Qiu M, Wulur IH, Liu J, Ehsani ME, Zhang C, Loboda A, Sung WK, Ag-garwal A, Poon RT, Fan ST, Wang J, Hardwick J, Reinhard C, Dai H, Li Y, Luk JM, Mao M. Whole-genome sequencing identifes recurrent mutations in hepatocellular carcinoma. Genome Res 2013; 23: 1422-1433 [PMID: 23788652 DOI: 10.1101/gr.154492.113]
33. Pinkel D, Albertson DG. Array comparative genomic hybridization and its applications in cancer. Nat Genet 2005; 37 Suppl: S11-S17 [PMID: 15920524 DOI: 10.1038/ng1569]
34. Djebali S, Davis CA, Merkel A, Dobin A, Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F, Xue C, Marinov GK, Khatun J, Williams BA, Zaleski C, Ro-zowsky J, Röder M, Kokocinski F, Abdelhamid RF, Alioto T, Antoshechkin I, Baer MT, Bar NS, Batut P, Bell K, Bell I, Chakrabortty S, Chen X, Chrast J, Curado J, Derrien T, Drenkow J, Dumais E, Dumais J, Duttagupta R, Falconnet E, Fastuca M, Fejes-Toth K, Ferreira P, Foissac S, Fullwood MJ, Gao H, Gonzalez D, Gordon A, Gunawardena H, Howald C, Jha S, Johnson R, Kapranov P, King B, Kingswood C, Luo OJ, Park E, Persaud K, Preall JB, Ribeca P, Risk B, Robyr D, Sammeth M, Schaffer L, See LH, Shahab A, Skancke J, Suzuki AM, Takahashi H, Tilgner H, Trout D, Walters N, Wang H, Wrobel J, Yu Y, Ruan X, Hayashizaki Y, Harrow J, Gerstein M, Hubbard T, Reymond A, Antonarakis SE, Han-non G, Giddings MC, Ruan Y, Wold B, Carninci P, Guigó R, Gingeras TR. Landscape of transcription in human cells. Nature 2012; 489: 101-108 [PMID: 22955620 DOI: 10.1038/na-ture11233]
35. Kallioniemi A, Kallioniemi OP, Sudar D, Rutovitz D, Gray JW, Waldman F, Pinkel D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science 1992; 258: 818-821 [PMID: 1359641 DOI: 10.1126/sci-ence.1359641]
36. Solinas-Toldo S, Lampel S, Stilgenbauer S, Nickolenko J, Benner A, Döhner H, Cremer T, Lichter P. Matrix-based comparative genomic hybridization: biochips to screen for genomic imbalances. Genes Chromosomes Cancer 1997; 20: 399-407 [PMID: 9408757 DOI: 10.1002/(SICI)1098-2264(1997 12)20:4<399::AID-GCC12>3.0.CO;2-I]
37. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C. dChipSNP: signifcance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 2004; 20: 1233-1240 [PMID: 14871870 DOI: 10.1093/bioinformatics/ bth069]
38. Chen CF, Hsu EC, Lin KT, Tu PH, Chang HW, Lin CH, Chen YJ, Gu DL, Lin CH, Wu JY, Chen YT, Hsu MT, Jou YS. Overlapping high-resolution copy number alterations in cancer genomes identifed putative cancer genes in hepato-cellular carcinoma. Hepatology 2010; 52: 1690-1701 [PMID: 20799341 DOI: 10.1002/hep.23847]
39. Shendure J, Ji H. Next-generation DNA sequencing. Nat Biotechnol 2008; 26: 1135-1145 [PMID: 18846087 DOI: 10.1038/nbt1486]
40. Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009; 458: 719-724 [PMID: 19360079 DOI: 10.1038/na-ture07943]
41. Brazma A, Parkinson H, Sarkans U, Shojatalab M, Vilo J, Abeygunawardena N, Holloway E, Kapushesky M, Kem-meren P, Lara GG, Oezcimen A, Rocca-Serra P, Sansone SA. ArrayExpress--a public repository for microarray gene expression data at the EBI. Nucleic Acids Res 2003; 31: 68-71 [PMID: 12519949]
42. Barrett T, Suzek TO, Troup DB, Wilhite SE, Ngau WC, Ledoux P, Rudnev D, Lash AE, Fujibuchi W, Edgar R. NCBI GEO: mining millions of expression profiles--database and tools. Nucleic Acids Res 2005; 33: D562-D566 [PMID: 15608262 DOI: 10.1093/nar/gki022]
43. Chen CF, Yeh SH, Chen DS, Chen PJ, Jou YS. Molecular genetic evidence supporting a novel human hepatocel-lular carcinoma tumor suppressor locus at 13q12.11. Genes Chromosomes Cancer 2005; 44: 320-328 [PMID: 16075462 DOI: 10.1002/gcc.20247]
44. Chang CY, Lin SC, Su WH, Ho CM, Jou YS. Somatic LMCD1 mutations promoted cell migration and tumor metastasis in hepatocellular carcinoma. Oncogene 2012; 31: 2640-2652 [PMID: 21996735 DOI: 10.1038/onc.2011.440]
45. Cheng N, Li Y, Han ZG. Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma. Hepatology 2013; 57: 1906-1918 [PMID: 23258480 DOI: 10.1002/hep.26202]
46. Wang K, Lim HY, Shi S, Lee J, Deng S, Xie T, Zhu Z, Wang Y, Pocalyko D, Yang WJ, Rejto PA, Mao M, Park CK, Xu J. Genomic landscape of copy number aberrations enables the identifcation of oncogenic drivers in hepatocellular carcinoma. Hepatology 2013; 58: 706-717 [PMID: 23505090 DOI: 10.1002/hep.26402]
47. Kwon SM, Kim DS, Won NH, Park SJ, Chwae YJ, Kang HC, Lee SH, Baik EJ, Thorgeirsson SS, Woo HG. Genomic copy number alterations with transcriptional deregulation at 6p identify an aggressive HCC phenotype. Carcinogenesis 2013; 34: 1543-1550 [PMID: 23508637 DOI: 10.1093/carcin/bgt095]
48. Kawamata N, Ogawa S, Zimmermann M, Niebuhr B, Stocking C, Sanada M, Hemminki K, Yamatomo G, Nannya Y, Koehler R, Flohr T, Miller CW, Harbott J, Ludwig WD, Stanulla M, Schrappe M, Bartram CR, Koeffer HP. Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic micro-array. Proc Natl Acad Sci USA 2008; 105: 11921-11926 [PMID: 18697940 DOI: 10.1073/pnas.0711039105]
49. Liang RC, Neo JC, Lo SL, Tan GS, Seow TK, Chung MC. Proteome database of hepatocellular carcinoma. J Chro-matogr B Analyt Technol Biomed Life Sci 2002; 771: 303-328 [PMID: 12016006]
50. Su WH, Chao CC, Yeh SH, Chen DS, Chen PJ, Jou YS. Onco DB. HCC: an integrated oncogenomic database of hepatocellular carcinoma revealed aberrant cancer target genes and loci. Nucleic Acids Res 2007; 35: D727-D731 [PMID: 17098932 DOI: 10.1093/nar/gkl845]
51. Hsu CN, Lai JM, Liu CH, Tseng HH, Lin CY, Lin KT, Yeh HH, Sung TY, Hsu WL, Su LJ, Lee SA, Chen CH, Lee GC, Lee DT, Shiue YL, Yeh CW, Chang CH, Kao CY, Huang CY. Detection of the inferred interaction network in hepatocellu-lar carcinoma from EHCO (Encyclopedia of Hepatocellular Carcinoma genes Online). BMC Bioinformatics 2007; 8: 66 [PMID: 17326819 DOI: 10.1186/1471-2105-8-66]
52. He B, Qiu X, Li P, Wang L, Lv Q, Shi T. HCCNet: an integrated network database of hepatocellular carcinoma. Cell Res 2010; 20: 732-734 [PMID: 20479783 DOI: 10.1038/ cr.2010.67]
53. Yu XJ, Fang F, Tang CL, Yao L, Yu L, Yu L. dbHCCvar: a comprehensive database of human genetic variations in hepatocellular carcinoma. Hum Mutat 2011; 32: E2308-E2316 [PMID: 21936021 DOI: 10.1002/humu.21595]
54. Staib F, Krupp M, Maass T, Itzel T, Weinmann A, Lee JS, Schmidt B, Müller M, Thorgeirsson SS, Galle PR, Teufel A. CellMinerHCC: a microarray-based expression database for hepatocellular carcinoma cell lines. Liver Int 2013 Jul 31; Epub ahead of print [PMID: 24016071 DOI: 10.1111/ liv.12292]
55. Schroeder MP, Gonzalez-Perez A, Lopez-Bigas N. Visualizing multidimensional cancer genomics data. Genome Med 2013; 5: 9 [PMID: 23363777 DOI: 10.1186/gm413]
56. Su G, Burant CF, Beecher CW, Athey BD, Meng F. Integrated metabolome and transcriptome analysis of the NCI60 dataset. BMC Bioinformatics 2011; 12 Suppl 1: S36 [PMID: 21342567 DOI: 10.1186/1471-2105-12-S1-S36]
57. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2012; 2: 401-404 [PMID: 22588877 DOI: 10.1158/2159-8290. CD-12-0095]
58. Forbes SA, Tang G, Bindal N, Bamford S, Dawson E, Cole C, Kok CY, Jia M, Ewing R, Menzies A, Teague JW, Stratton MR, Futreal PA. COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer. Nucleic Acids Res 2010; 38: D652-D657 [PMID: 19906727 DOI: 10.1093/nar/gkp995]
59. Joly Y, Dove ES, Knoppers BM, Bobrow M, Chalmers D. Data sharing in the post-genomic world: the experience of the International Cancer Genome Consortium (ICGC) Data Access Compliance Offce (DACO). PLoS Comput Biol 2012; 8: e1002549 [PMID: 22807659 DOI: 10.1371/journal. pcbi.1002549]
60. Goldman M, Craft B, Swatloski T, Ellrott K, Cline M, Diekhans M, Ma S, Wilks C, Stuart J, Haussler D, Zhu J. The UCSC Cancer Genomics Browser: update 2013. Nucleic Acids Res 2013; 41: D949-D954 [PMID: 23109555 DOI: 10.1093/ nar/gks1008]